Suchergebnisse - "Guglielmetti, Lorenzo"

PubPharm (16)

1

Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis : A Systematic Review and Meta-Analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Holmgaard, F. | Guglielmetti, L. | Lillebaek, T. | +3

2

Evidence-based Definition for Extensively Drug-Resistant Tuberculosis

enthalten in: American journal of respiratory and critical care medicine | 2021

von Roelens, M. | Battista Migliori, G. | Rozanova, L. | +15

CommentIn: Am J Respir Crit Care Med. 2021 Sep 15;204(6):629-631. - PMID 34375572

3

The coming-of-age of bedaquiline : a tale with an open ending

enthalten in: The European respiratory journal | 2021

von Guglielmetti, L. | Varaine, F.

CommentOn: Eur Respir J. 2021 Jun 10;57(6):. - PMID 33334942

4

Bedaquiline and delamanid for drug-resistant tuberculosis : a clinician's perspective

enthalten in: Future microbiology | 2020

von Guglielmetti, L. | Chiesi, S. | Eimer, J. | +6

5

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis : an individual patient data meta-analysis

enthalten in: The Lancet. Respiratory medicine | 2020

von Lan, Z. | Ahmad, N. | Baghaei, P. | +42

6

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

enthalten in: Emerging infectious diseases | 2019

von Mbuagbaw, L. | Guglielmetti, L. | Hewison, C. | +12

7

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis : How Much Better Are They?

enthalten in: American journal of respiratory and critical care medicine | 2018

von Bastard, M. | Guglielmetti, L. | Huerga, H. | +7

8

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis : an individual patient data meta-analysis

enthalten in: Lancet (London, England) | 2018

von Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 | Ahmad, N. | Ahuja, S. | +98

CommentIn: Lancet. 2018 Sep 8;392(10150):797-798. - PMID 30215367

9

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe : a Tuberculosis Network European Trialsgroup (TBnet) study

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Tiberi, S. | Burman, M. | +66

10

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis : a case series from France and Latvia

enthalten in: The European respiratory journal | 2018

von Guglielmetti, L. | Barkane, L. | Le Dû, D. | +7